Bessemer Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,939
| Closed | -$589K | – | 1860 |
|
|
2019
Q3 | $589K | Sell |
5,939
-928
| -14% | -$88.2K | ﹤0.01% | 836 |
|
|
2019
Q2 | $635K | Sell |
6,867
-2,058
| -23% | -$195K | ﹤0.01% | 818 |
|
|
2019
Q1 | $842K | Sell |
8,925
-882
| -9% | -$77.1K | ﹤0.01% | 677 |
|
|
2018
Q4 | $629K | Sell |
9,807
-6,534
| -40% | -$482K | ﹤0.01% | 696 |
|
|
2018
Q3 | $1.46M | Buy |
16,341
+1,211
| +8% | +$107K | 0.01% | 493 |
|
|
2018
Q2 | $1.2M | Sell |
15,130
-2,176
| -13% | -$181K | ﹤0.01% | 533 |
|
|
2018
Q1 | $1.54M | Buy |
17,306
+734
| +4% | +$70.5K | 0.01% | 468 |
|
|
2017
Q4 | $1.73M | Buy |
16,572
+674
| +4% | +$76.1K | 0.01% | 450 |
|
|
2017
Q3 | $2.32M | Sell |
15,898
-1,074
| -6% | -$146K | 0.01% | 417 |
|
|
2017
Q2 | $2.21M | Buy |
16,972
+5,359
| +46% | +$657K | 0.01% | 434 |
|
|
2017
Q1 | $1.45M | Buy |
11,613
+271
| +2% | +$32.4K | 0.01% | 599 |
|
|
2016
Q4 | $1.31M | Sell |
11,342
-2,435
| -18% | -$271K | 0.01% | 636 |
|
|
2016
Q3 | $1.44M | Sell |
13,777
-3,115
| -18% | -$337K | 0.01% | 530 |
|
|
2016
Q2 | $1.67M | Buy |
16,892
+485
| +3% | +$50.2K | 0.01% | 410 |
|
|
2016
Q1 | $1.64M | Sell |
16,407
-14,552
| -47% | -$1.5M | 0.01% | 411 |
|
|
2015
Q4 | $3.71M | Buy |
30,959
+3,197
| +12% | +$370K | 0.02% | 308 |
|
|
2015
Q3 | $3M | Buy |
27,762
+18,169
| +189% | +$2.25M | 0.02% | 344 |
|
|
2015
Q2 | $1.11M | Sell |
9,593
-2,192
| -19% | -$251K | 0.01% | 525 |
|
|
2015
Q1 | $1.36M | Buy |
11,785
+3,976
| +51% | +$475K | 0.01% | 474 |
|
|
2014
Q4 | $873K | Buy |
7,809
+2,055
| +36% | +$217K | ﹤0.01% | 502 |
|
|
2014
Q3 | $546K | Buy |
5,754
+354
| +7% | +$31.9K | ﹤0.01% | 568 |
|
|
2014
Q2 | $464K | Sell |
5,400
-4,410
| -45% | -$335K | ﹤0.01% | 586 |
|
|
2014
Q1 | $683K | Buy |
9,810
+40
| +0.4% | +$3.17K | ﹤0.01% | 490 |
|
|
2013
Q4 | $826K | Buy |
9,770
+664
| +7% | +$52.5K | 0.01% | 462 |
|
|
2013
Q3 | $703K | Sell |
9,106
-1,920
| -17% | -$135K | 0.01% | 471 |
|
|
2013
Q2 | $645K | Buy |
+11,026
| New | +$664K | 0.01% | 435 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bessemer Group's CELG Position: Q4 2019 in Review
Bessemer Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,939 shares — an estimated $589K sold.
Bessemer Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.71M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bessemer Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bessemer Group sold 5,939 Celgene Corp shares in Q4 2019, an estimated $589K.
- Bessemer Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bessemer Group's Celgene Corp position peaked at $3.71M in Q4 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bessemer Group's 13F filing for Q4 2019, filed 4 Feb 2020.